Arjun Kumar Manrai, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glomerular Filtration Rate | 5 | 2022 | 2227 | 1.390 |
Why?
|
| Artificial Intelligence | 8 | 2024 | 2665 | 1.060 |
Why?
|
| Computational Biology | 8 | 2021 | 3568 | 0.960 |
Why?
|
| Creatinine | 4 | 2022 | 1918 | 0.870 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2022 | 2298 | 0.850 |
Why?
|
| Social Values | 1 | 2024 | 224 | 0.850 |
Why?
|
| Nutrition Surveys | 8 | 2024 | 1738 | 0.790 |
Why?
|
| Kidney | 3 | 2021 | 7064 | 0.740 |
Why?
|
| Eligibility Determination | 1 | 2024 | 421 | 0.720 |
Why?
|
| Reference Values | 5 | 2021 | 4938 | 0.700 |
Why?
|
| Statistics as Topic | 2 | 2018 | 2357 | 0.680 |
Why?
|
| Thumb | 1 | 2021 | 232 | 0.670 |
Why?
|
| Respiratory Function Tests | 1 | 2024 | 1695 | 0.650 |
Why?
|
| Kidney Function Tests | 1 | 2021 | 684 | 0.610 |
Why?
|
| Biostatistics | 1 | 2019 | 163 | 0.570 |
Why?
|
| Aortic Aneurysm | 1 | 2021 | 649 | 0.550 |
Why?
|
| Primary Prevention | 1 | 2024 | 1188 | 0.550 |
Why?
|
| False Positive Reactions | 2 | 2016 | 963 | 0.540 |
Why?
|
| Data Mining | 1 | 2021 | 563 | 0.530 |
Why?
|
| Genetic Variation | 5 | 2021 | 6611 | 0.520 |
Why?
|
| Disease | 3 | 2019 | 675 | 0.520 |
Why?
|
| Epidemiologic Research Design | 1 | 2019 | 368 | 0.500 |
Why?
|
| Respiratory Insufficiency | 1 | 2024 | 1240 | 0.490 |
Why?
|
| Genomics | 5 | 2021 | 5926 | 0.490 |
Why?
|
| Antihypertensive Agents | 1 | 2024 | 2029 | 0.470 |
Why?
|
| Penetrance | 1 | 2016 | 385 | 0.450 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2018 | 747 | 0.420 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2019 | 789 | 0.420 |
Why?
|
| RNA, Ribosomal | 1 | 2013 | 227 | 0.410 |
Why?
|
| Environmental Exposure | 3 | 2017 | 4543 | 0.400 |
Why?
|
| Chemokine CXCL10 | 1 | 2013 | 311 | 0.400 |
Why?
|
| Virulence | 1 | 2016 | 1297 | 0.390 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2021 | 1334 | 0.370 |
Why?
|
| Genome, Human | 3 | 2021 | 4446 | 0.360 |
Why?
|
| Genetic Testing | 4 | 2021 | 3591 | 0.350 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3251 | 0.330 |
Why?
|
| Data Interpretation, Statistical | 1 | 2019 | 2709 | 0.320 |
Why?
|
| Databases, Genetic | 4 | 2021 | 1758 | 0.290 |
Why?
|
| Physicians | 2 | 2023 | 4598 | 0.270 |
Why?
|
| Models, Chemical | 1 | 2008 | 611 | 0.270 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 15454 | 0.260 |
Why?
|
| Environmental Health | 2 | 2021 | 298 | 0.250 |
Why?
|
| Biomedical Research | 2 | 2020 | 3463 | 0.240 |
Why?
|
| Veterans Disability Claims | 1 | 2024 | 24 | 0.230 |
Why?
|
| Aging | 2 | 2020 | 8744 | 0.220 |
Why?
|
| Humans | 42 | 2024 | 768166 | 0.220 |
Why?
|
| Myocardial Infarction | 1 | 2024 | 11519 | 0.220 |
Why?
|
| Public Health | 1 | 2016 | 2679 | 0.220 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 2892 | 0.220 |
Why?
|
| Diagnosis | 1 | 2023 | 156 | 0.210 |
Why?
|
| Stroke | 1 | 2024 | 9755 | 0.200 |
Why?
|
| Mathematical Concepts | 1 | 2021 | 75 | 0.190 |
Why?
|
| Spirometry | 1 | 2024 | 929 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2019 | 18065 | 0.180 |
Why?
|
| Delphi Technique | 1 | 2024 | 891 | 0.180 |
Why?
|
| Financing, Government | 1 | 2024 | 473 | 0.180 |
Why?
|
| Graft Rejection | 1 | 2013 | 4492 | 0.170 |
Why?
|
| Cystatin C | 1 | 2021 | 272 | 0.170 |
Why?
|
| American Heart Association | 1 | 2024 | 1050 | 0.170 |
Why?
|
| Phosphoproteins | 1 | 2008 | 2451 | 0.170 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2024 | 3252 | 0.160 |
Why?
|
| RNA, Messenger | 1 | 2013 | 12800 | 0.150 |
Why?
|
| Kidney Transplantation | 1 | 2013 | 4262 | 0.150 |
Why?
|
| Cardiac Myosins | 1 | 2018 | 128 | 0.140 |
Why?
|
| Disability Evaluation | 1 | 2024 | 1835 | 0.140 |
Why?
|
| Hand | 1 | 2021 | 913 | 0.130 |
Why?
|
| Myosin Heavy Chains | 1 | 2018 | 404 | 0.130 |
Why?
|
| Reproducibility of Results | 4 | 2020 | 20227 | 0.130 |
Why?
|
| Adult | 10 | 2024 | 223646 | 0.130 |
Why?
|
| Occupational Diseases | 1 | 2024 | 1457 | 0.130 |
Why?
|
| Eye Diseases | 1 | 2021 | 660 | 0.130 |
Why?
|
| Probability | 1 | 2021 | 2479 | 0.130 |
Why?
|
| Models, Statistical | 2 | 2021 | 5107 | 0.130 |
Why?
|
| Software | 4 | 2021 | 4478 | 0.120 |
Why?
|
| Consensus | 1 | 2024 | 3212 | 0.120 |
Why?
|
| Language | 1 | 2024 | 1557 | 0.120 |
Why?
|
| Lung Transplantation | 1 | 2024 | 1309 | 0.120 |
Why?
|
| Medicine | 1 | 2023 | 945 | 0.120 |
Why?
|
| Hemochromatosis | 1 | 2016 | 175 | 0.120 |
Why?
|
| Selection Bias | 1 | 2016 | 360 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2024 | 1944 | 0.110 |
Why?
|
| Enkephalins | 1 | 2014 | 139 | 0.110 |
Why?
|
| Siblings | 1 | 2017 | 828 | 0.110 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2018 | 606 | 0.100 |
Why?
|
| Contractile Proteins | 1 | 2014 | 240 | 0.100 |
Why?
|
| Male | 13 | 2024 | 364719 | 0.100 |
Why?
|
| Ecosystem | 1 | 2016 | 494 | 0.100 |
Why?
|
| Gene Frequency | 2 | 2018 | 3623 | 0.100 |
Why?
|
| United States | 6 | 2024 | 73039 | 0.100 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 26379 | 0.100 |
Why?
|
| Laboratories | 1 | 2016 | 463 | 0.100 |
Why?
|
| Risk | 1 | 2024 | 9613 | 0.100 |
Why?
|
| Female | 12 | 2024 | 397192 | 0.100 |
Why?
|
| Uncertainty | 1 | 2016 | 769 | 0.090 |
Why?
|
| Telomere | 1 | 2017 | 944 | 0.090 |
Why?
|
| Cause of Death | 1 | 2021 | 3721 | 0.090 |
Why?
|
| Aged | 6 | 2024 | 171504 | 0.090 |
Why?
|
| Risk Factors | 7 | 2023 | 74944 | 0.080 |
Why?
|
| Protein Precursors | 1 | 2014 | 1134 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 832 | 0.080 |
Why?
|
| Young Adult | 3 | 2024 | 60066 | 0.080 |
Why?
|
| Middle Aged | 7 | 2024 | 223492 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2024 | 24315 | 0.080 |
Why?
|
| Heterozygote | 1 | 2016 | 2798 | 0.080 |
Why?
|
| Child | 4 | 2024 | 80917 | 0.080 |
Why?
|
| Adolescent | 4 | 2024 | 89169 | 0.080 |
Why?
|
| Delivery of Health Care | 2 | 2024 | 5367 | 0.080 |
Why?
|
| Interleukin-10 | 1 | 2014 | 1183 | 0.080 |
Why?
|
| Phosphotransferases | 1 | 2008 | 302 | 0.070 |
Why?
|
| Information Dissemination | 1 | 2016 | 1143 | 0.070 |
Why?
|
| Research Design | 1 | 2023 | 6211 | 0.070 |
Why?
|
| Nucleic Acid Probes | 1 | 2007 | 8 | 0.070 |
Why?
|
| Shock, Septic | 1 | 2014 | 774 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 3533 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 7454 | 0.070 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2008 | 414 | 0.070 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 2744 | 0.070 |
Why?
|
| Glycoproteins | 1 | 2014 | 2202 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2016 | 3447 | 0.060 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2009 | 792 | 0.060 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 2056 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 4786 | 0.060 |
Why?
|
| Algorithms | 3 | 2024 | 14164 | 0.060 |
Why?
|
| Health Status Disparities | 1 | 2016 | 1885 | 0.060 |
Why?
|
| Genome-Wide Association Study | 2 | 2020 | 12795 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 2009 | 1089 | 0.050 |
Why?
|
| Genotype | 1 | 2016 | 13045 | 0.050 |
Why?
|
| Phenotype | 4 | 2021 | 16726 | 0.050 |
Why?
|
| Bioethics | 1 | 2021 | 118 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2020 | 42669 | 0.040 |
Why?
|
| Proteins | 1 | 2014 | 6009 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 1930 | 0.040 |
Why?
|
| Computer Communication Networks | 1 | 2020 | 295 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3800 | 0.040 |
Why?
|
| Infant | 1 | 2020 | 36535 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2008 | 8317 | 0.040 |
Why?
|
| Twins | 1 | 2019 | 341 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 12252 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2021 | 81762 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2021 | 1328 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 59629 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 8647 | 0.030 |
Why?
|
| Environment | 1 | 2019 | 1121 | 0.030 |
Why?
|
| Models, Biological | 1 | 2008 | 9495 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 30238 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2009 | 165 | 0.020 |
Why?
|
| Leukocytes | 1 | 2017 | 2035 | 0.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2009 | 197 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 5536 | 0.020 |
Why?
|
| Smoking | 1 | 2023 | 9092 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5884 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1656 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 2094 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2009 | 11101 | 0.020 |
Why?
|
| Alleles | 1 | 2018 | 6894 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2007 | 177 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2019 | 2517 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 2414 | 0.020 |
Why?
|
| Self Report | 1 | 2017 | 3773 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 3858 | 0.010 |
Why?
|
| Gene Expression | 1 | 2017 | 7598 | 0.010 |
Why?
|
| Sex Factors | 1 | 2017 | 10632 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 12077 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 1750 | 0.010 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2014 | 1672 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2017 | 8080 | 0.010 |
Why?
|
| Androgens | 1 | 2009 | 1281 | 0.010 |
Why?
|
| Cell Division | 1 | 2009 | 4473 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 16045 | 0.010 |
Why?
|
| Genome | 1 | 2009 | 1754 | 0.010 |
Why?
|
| Proteomics | 1 | 2014 | 3912 | 0.010 |
Why?
|
| Histones | 1 | 2009 | 2601 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 9538 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2007 | 1470 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 54926 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 12421 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 17140 | 0.010 |
Why?
|
| Animals | 2 | 2014 | 169246 | 0.000 |
Why?
|
| Mice | 1 | 2014 | 82029 | 0.000 |
Why?
|